Navigation Links
New Antibiotics, Need Of The Hour: IDSA

The pharmaceutical companies have been urged to produce more antibiotics by the Infectious Diseases Society of America (IDSA). The federal legislation// is being encouraged to provide drug companies with incentives to do so.

Combating the drug-resistant microbes should deserve the utmost priority owing to the health risks involved. No anti-biotics have so far been developed to treat such life-threatening infections. The pathogenic organisms against which effective drugs have to be developed include methicillin-resistant staphylococcus aureus, E-coli, acinetobacter baumannii, klebsiella, vancomycin-resistant enterococcus faecium pseudomonas aeruginosa and aspergillus.

Infections with the above-mentioned organisms pose a significant threat to the survival of the individual. Moreover, these infections are seen frequently in the medical set up that aggravates the need for development of novel treatment strategies.

There has been a steady decrease in the number of antimicrobials, approved by the FDA over the past 20 years. Major pharmaceutical companies have diverted their attention to other medical problems, leading to a large lacuna in this demanding field.

While acknowledging that drug development and marketing has to undergo several phases of rigorous testing that may take several months or even years, the organization has appealed to the Congress to pass a broad legislation that would enable provision of market-exclusive rights to drug companies that come out with startling discoveries.

Such companies can then be encouraged through provision of tax credits that would encourage research and development and drug manufacture.


'"/>




Page: 1

Related medicine news :

1. Promotion Of Medical Research In India Is The Need Of The Hour: ICMR
2. Need of the Hour: Viable Strategies against AIDS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... 2016 , ... Regenerative Medicine is being transformed by ongoing research and clinical ... and patient results as have been achieved with Okyanos Cell Therapy are ... care for patients worldwide. , As the Medical Advisory Chairman at Okyanos, Eric Duckers, ...
(Date:5/24/2016)... ... ... Boyd Industries, a leading supplier of dental chairs and cabinetry , will ... dentistry , at AAPD 2016, the annual conference and trade show of the American ... keeps dental hand pieces and other anxiety-provoking pieces of the dental delivery system out ...
(Date:5/24/2016)... ... , ... Growing in popularity, more and more people continue to live their ... accessible. Whether someone chooses to cut gluten out of their life for personal health ... stocks their shelves with many different gluten-free products all year round. And they take ...
(Date:5/24/2016)... Lake Orion, Michigan (PRWEB) , ... May 24, 2016 , ... ... Aroma Yoga. , The Yoga practice enhanced with Young Living Essential Oils, taught ... 6:30pm - 8pm at the Lake Orion location. Yoga Flow is 6:30pm - 7:15pm ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Controlling and maintaining ... with the launch of the Aquanta Water Heater Controller , a first-of-its-kind system ... or web-enabled device. As the Nest thermostat does for HVAC systems, Aquanta gives ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... AMSTERDAM , May 24, 2016 ... auf den Markt gebracht, die es Ärzten erlaubt, ... überall zu behandeln: MDLinking kombiniert Live Streaming mit ... sicheren Umfeld zu kommunizieren. Mediziner in Europa, Afrika, ... haben sich bereits für die Plattform registriert. ...
(Date:5/24/2016)... Cirujanos holandeses han puesto en ... médicos a compartir sus mejores prácticas por el mundo ... médicos de Europa, África, Asia ... aplicación, que combina la transmisión en vivo con mensajería ... Educación   "Imagine un médico de Medicines ...
(Date:5/24/2016)... 2016   ... primären Endpunkte und demonstriert Ebenbürtigkeit bei der ... ‚ausgezeichneter plus guter , Reinigung ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... Daten von der MORA-Studie der Phase III für ...
Breaking Medicine Technology: